- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Reneo Pharmaceuticals (NASDAQ:RPHM), Quotes and News Summary
Reneo Pharmaceuticals (NASDAQ: RPHM)
Earnings
see more| FY 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-12-20 | ||||||
| REV | |||||||
| FY 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-11-09 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Reneo Pharmaceuticals Questions & Answers
You can purchase shares of Reneo Pharmaceuticals (NASDAQ: RPHM) through any online brokerage.
Other companies in Reneo Pharmaceuticals’s space includes: Orchard Therapeutics (NASDAQ:ORTX), Virios Therapeutics (NASDAQ:VIRI), Lumos Pharma (NASDAQ:LUMO), Evaxion Biotech (NASDAQ:EVAX) and Aligos Therapeutics (NASDAQ:ALGS).
The latest price target for Reneo Pharmaceuticals (NASDAQ: RPHM) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting RPHM to rise to within 12 months (a possible 44.40% upside). 50 analyst firms have reported ratings in the last year.
The stock price for Reneo Pharmaceuticals (NASDAQ: RPHM) is $2.77 last updated August 12, 2022, 8:00 PM UTC.
The next Reneo Pharmaceuticals (RPHM) dividend date is projected to be Thursday, September 1, 2022.
Reneo Pharmaceuticals’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Reneo Pharmaceuticals.
Reneo Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.